We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company
LJPC

Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

76 hedge funds and large institutions have $86M invested in La Jolla Pharmaceutical Company in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 18

18% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 17

8% more capital invested

Capital invested by funds: $79.4M → $86M (+$6.62M)

4% more funds holding

Funds holding: 73 → 76 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

15% less call options, than puts

Call options by funds: $378K | Put options by funds: $444K

Holders
76
Holders Change
+3
Holders Change %
+4.11%
% of All Funds
1.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
20
Increased
24
Reduced
18
Closed
17
Calls
$378K
Puts
$444K
Net Calls
-$66K
Net Calls Change
+$33K

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$3.75M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$2.28M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$2.14M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.52M
5
EIM
Essex Investment Management
Massachusetts
+$1.41M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.03M
2
FMBTD
First Midwest Bank Trust Division
Illinois
-$614K
3
PP
PDT Partners
New York
-$463K
4
WVP
Worth Venture Partners
New Jersey
-$358K
5
BlackRock
BlackRock
New York
-$353K
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$245K +$353K +58,028 New
Deutsche Bank
27
Deutsche Bank
Germany
$237K +$52.9K +8,689 +18%
EGM
28
Engineers Gate Manager
New York
$225K +$157K +25,800 +96%
Wells Fargo
29
Wells Fargo
California
$217K +$51.7K +8,494 +20%
Principal Financial Group
30
Principal Financial Group
Iowa
$202K +$289K +47,508 New
Prudential Financial
31
Prudential Financial
New Jersey
$200K +$285K +46,880 New
DCM
32
Dupont Capital Management
Delaware
$196K +$281K +46,118 New
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$180K +$62.7K +10,300 +32%
Citadel Advisors
34
Citadel Advisors
Florida
$158K -$76K -12,487 -25%
Goldman Sachs
35
Goldman Sachs
New York
$151K +$87.4K +14,358 +68%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$137K – – –
FMBTD
37
First Midwest Bank Trust Division
Illinois
$125K -$614K -100,822 -77%
HCM
38
Hollencrest Capital Management
California
$119K +$110K +18,000 +180%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$113K -$1.35K -221 -0.8%
TRCT
40
Tower Research Capital (TRC)
New York
$106K +$152K +25,011 New
GC
41
Grimes & Company
Massachusetts
$100K – – –
AQR Capital Management
42
AQR Capital Management
Connecticut
$98K +$54.8K +9,006 +64%
VF
43
Virtu Financial
New York
$95K +$136K +22,411 New
S
44
SignatureFD
Georgia
$94K +$134K +22,000 New
BFM
45
Boothbay Fund Management
New York
$88K +$13.5K +2,220 +12%
UBS Group
46
UBS Group
Switzerland
$84K -$40K -6,561 -25%
Simplex Trading
47
Simplex Trading
Illinois
$83K -$22.6K -3,707 -16%
Bank of America
48
Bank of America
North Carolina
$69K -$1.96K -322 -2%
WS
49
Wedbush Securities
California
$64K +$91.3K +15,000 New
State Board of Administration of Florida Retirement System
50
State Board of Administration of Florida Retirement System
Florida
$63K – – –
1
2
3 4

LJPC Hedge Fund Activity: Q2 2020 in Review

76 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q2 2020, worth a combined $86M — up 8.3% from $79.4M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new LJPC positions and 17 closed out — a net gain of 3 holders — while 24 added to existing stakes and 18 trimmed.

The largest buyer was Tang Capital Management, adding an estimated $3.75M. The largest seller was Fidelity Investments, cutting an estimated $7.03M.

  • 76 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q2 2020, up from 73 in Q1 2020.
  • Funds reported $86M of La Jolla Pharmaceutical Company stock for Q2 2020, up 8.3% quarter-over-quarter.
  • 20 funds opened new La Jolla Pharmaceutical Company positions in Q2 2020 and 17 closed out, a net change of +3 holders.
  • The largest La Jolla Pharmaceutical Company buyer in Q2 2020 was Tang Capital Management, an estimated $3.75M added.
  • The largest La Jolla Pharmaceutical Company seller in Q2 2020 was Fidelity Investments, an estimated $7.03M sold.

Based on aggregated 13F filings for Q2 2020.